Immunitas Therapeutics logo
Healthcare & Life Sciences

Immunitas Therapeutics

Immunitas Therapeutics is a series b startup based in United States. 1 investor tracked. Status: zombie.

zombieseries-b
series-b
Stage
2019
Founded
2
Investors

About Immunitas Therapeutics

Immunitas Therapeutics is a startup founded in 2019 based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.

Immunitas Therapeutics is a single-cell genomics-based therapeutics company focused on discovering and developing novel, targeted-immunology medicines for cancer.

Explore Immunitas Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States